Posts

University of Arkansas Joins U.S. Army Pathfinder Program

The University of Arkansas has become the latest university to join the Army Pat...

Johns Hopkins APL creates autonomy safety net for AFWER...

The Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, is equip...

Controlling the source of electromagnetic waves enables...

Since the scientists at Bell Labs invented the world’s first transistor in Decem...

Advancing metasurface manufacturing with water-soluble ...

When will the protruding rear camera on smartphones become obsolete? The impleme...

SLAC researchers take important step toward developing ...

Researchers have announced an important step in the development of a next-gen te...

Team compares reanalysis datasets with Advanced Himawar...

Today’s weather satellites provide scientists with a unique opportunity to evalu...

£7 million award for quantum engineering of energy-effi...

A world leading team of scientists has been awarded over £7M to develop radicall...

House Democrats unveil new legislation that expands the...

In July, Democratic health leaders from the US House of Representatives proposed...

Botulinum battle heats up with FDA approving Daxxify fo...

Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to t...

LifeArc invests nearly $10m in Crick Institute’s Africa...

The funding will extend support to the Institute’s Crick Africa Network for five...

Valneva pushes FDA approval date for chikungunya vaccine

The PDUFA date has been pushed by three months to November to allow for more tim...

Novartis acquires Chinook for $3.2bn to boost kidney di...

Novartis obtains two Phase III drugs, atrasentan and zigakibart, and Chinook is ...

How the pharma industry can benefit from using modular ...

New advancements in cold chain monitoring are poised to revolutionise the pharma...

RNA-LNPs: Navigating the regulatory challenges

We discuss why demand for ionizable lipid mixes for delivery and target validati...

ImPact enters partnership for pathologic myopia therapy...

ImPact Biotech entered into a partnership with Maastricht University to develop ...

Biopharma firm Zetagen raises $9.79m in Series B financ...

Zetagen Therapeutics raised $9.79m in a Series B funding round to develop treatm...